TCM
ALDX icon

Tang Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History

Tang Capital Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-272,293
Closed -$1.9M – 104
2022
Q4 		$1.9M Sell
272,293
-427,707
-61% -$2.45M 0.28% 62
2022
Q3 		$3.74M Buy
+700,000
New +$4.2M 0.46% 49

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tang Capital Management's ALDX Position: Q1 2023 in Review

Tang Capital Management sold out of Aldeyra Therapeutics (ALDX) in Q1 2023, closing a stake of 272,293 shares — an estimated $1.9M sold.

Tang Capital Management first reported a position in ALDX in Q3 2022 and held it in 2 quarters. The position peaked at $3.74M in Q3 2022. 108 funds tracked by Wall St. Rank hold ALDX as of Q1 2023.

  • Tang Capital Management reported no remaining Aldeyra Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Tang Capital Management sold 272,293 Aldeyra Therapeutics shares in Q1 2023, an estimated $1.9M.
  • Tang Capital Management first reported a position in Aldeyra Therapeutics in Q3 2022 and held it in 2 quarters.
  • Tang Capital Management's Aldeyra Therapeutics position peaked at $3.74M in Q3 2022.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2023.

Based on Tang Capital Management's 13F filing for Q1 2023, filed 15 May 2023.